Pancreatic cancer epidermal growth factor receptor (EGFR) intron 1 polymorphism influences postoperative patient survival and in vitro erlotinib response.

Source:http://linkedlifedata.com/resource/pubmed/id/17453292

Download in:

View as

General Info

PMID
17453292